Autopsy report · NCT01518595

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis

“too slow patient recruitment”

The sponsor’s own words in the registry.

Life of this trial

• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Medical University of Vienna

Sponsor type

University, hospital or other

Conditions

Hepatopulmonary Syndrome; Liver Cirrhosis

Interventions

bosentan; Placebo

Participants

6

Sites

1

Countries

Austria

Trials that died the same way

• Evaluation of the Parietex TM Parastomal No Hole Mesh for Repair of Parastomal Hernias in End-colostomies
  “too slow patiënts recruitment” (97% match in meaning)
• A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
  “slow patient recruitment” (97% match in meaning)
• Growth Hormone in Poor Responders to IVF Trial
  “Insufficient/slow patient recruitment” (95% match in meaning)
• The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
  “Slow recruitment of patients” (90% match in meaning)
• Fesoterodine on Urgency Episodes in Parkinson's Disease Population
  “Insufficient or untimely patient recruitment” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.